Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Free Cash Flow Generation Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Free Cash Flow Generation Index of 0.84x as of September 2025. Free cash flow of CN¥192.09 Million represents 1% of operating cash flow (CN¥227.64 Million). See Zhejiang Jingxin Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. Explore Zhejiang Jingxin Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | CN¥578.50 Million | CN¥781.35 Million | CN¥202.85 Million | ▲ +13.1% |
| 2024 | 0.65x | CN¥475.52 Million | CN¥726.16 Million | CN¥250.65 Million | ▲ +97.6% |
| 2023 | 0.33x | CN¥273.32 Million | CN¥824.69 Million | CN¥519.51 Million | ▼ -16.6% |
| 2022 | 0.40x | CN¥340.20 Million | CN¥855.78 Million | CN¥515.57 Million | ▲ +468.2% |
| 2021 | -0.11x | CN¥-39.41 Million | CN¥365.02 Million | CN¥404.43 Million | ▼ -130.9% |
| 2020 | 0.35x | CN¥179.21 Million | CN¥513.21 Million | CN¥334.00 Million | ▼ -5.6% |
| 2019 | 0.37x | CN¥197.97 Million | CN¥535.30 Million | CN¥337.33 Million | ▼ -31.2% |
| 2018 | 0.54x | CN¥281.21 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -24.2% |
| 2017 | 0.71x | CN¥272.82 Million | CN¥385.01 Million | CN¥112.19 Million | ▲ +13.7% |
| 2016 | 0.62x | CN¥157.43 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +196.7% |
| 2015 | 0.21x | CN¥30.39 Million | CN¥144.69 Million | CN¥114.31 Million | ▼ -61.8% |
| 2014 | 0.55x | CN¥115.74 Million | CN¥210.49 Million | CN¥94.75 Million | ▲ +2117.5% |
| 2013 | 0.02x | CN¥2.75 Million | CN¥111.03 Million | CN¥108.28 Million | ▲ +106.4% |
| 2012 | -0.39x | CN¥-23.23 Million | CN¥60.28 Million | CN¥83.51 Million | ▼ -993.9% |
| 2011 | -0.04x | CN¥-2.45 Million | CN¥69.41 Million | CN¥71.86 Million | ▲ +97.8% |
| 2010 | -1.62x | CN¥-96.32 Million | CN¥59.55 Million | CN¥155.87 Million | ▼ -290.1% |
| 2009 | 0.85x | CN¥115.20 Million | CN¥135.38 Million | CN¥20.18 Million | ▲ +284.5% |
| 2008 | -0.46x | CN¥-13.83 Million | CN¥29.98 Million | CN¥43.81 Million | ▲ +60.9% |
| 2005 | -1.18x | CN¥-72.85 Million | CN¥61.82 Million | CN¥134.67 Million | ▲ +91.7% |
| 2004 | -14.26x | CN¥-91.68 Million | CN¥6.43 Million | CN¥98.11 Million | ▼ -2531.7% |
| 2003 | -0.54x | CN¥-25.01 Million | CN¥46.18 Million | CN¥71.19 Million | ▼ -973.6% |
| 2002 | -0.05x | CN¥-2.30 Million | CN¥45.50 Million | CN¥47.79 Million | — |